北美前列腺癌诊断市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Medical Devices North America Prostate Cancer Diagnostics Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美前列腺癌诊断市场 – 行业趋势和 2028 年预测

  • Medical Devices
  • Published Report
  • Mar 2021
  • North America
  • 350 页面
  • 桌子數： 94
  • 图号： 55
立即购买 立即购买

>北美前列腺癌诊断市场，按产品类型（仪器、试剂、耗材和配件）、诊断类型（初步筛查试验、确认试验）、年龄组（成人、儿童和老年病学）、类型（前列腺腺癌、小细胞癌等）、分期（局限性前列腺癌、复发性/晚期前列腺癌和去势抵抗性前列腺癌（转移性和非转移性））、样本类型（血液、组织、尿液等）、最终用户（独立诊断实验室、医院、癌症研究机构、诊所、门诊手术中心等）、分销渠道（直接招标、零售）、国家（美国、加拿大和墨西哥）划分的行业趋势和预测（至 2028 年）  

北美前列腺癌诊断市场市场分析与洞察：北美前列腺癌诊断市场

前列腺癌诊断市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 12.9%，预计到 2028 年将达到 36.3144 亿美元。对疾病负担的关注度不断提高和对疾病的认识不断提高是预测期内推动前列腺癌诊断市场发展的主要驱动力。

当前列腺细胞开始以异常速度生长时，前列腺癌就开始了，这种情况被称为前列腺癌。前列腺是男性特有的腺体。它会产生精液中的部分液体。前列腺癌诊断是一种主要在早期检测癌症的技术，以便进行未来的治疗方法，从而提高存活率。

前列腺癌的发展与年龄密切相关，随着老年人口的增加，前列腺癌的发病率显著增加。这将增加对用于检测疾病的诊断产品的需求，并有望成为前列腺癌诊断市场的驱动力。PSA 检测是用于前列腺癌检测的主要检测之一。然而，政府和医疗服务提供商在使用 PSA 和相关检测方面的矛盾预计将制约前列腺癌诊断市场的发展。该市场具有巨大的增长潜力，随着新市场参与者试图通过分销协议利用业务扩张进入市场，并已投资于前列腺癌诊断，预计市场规模将扩大，并将为前列腺癌诊断市场带来机遇。与进行癌症诊断测试相关的障碍可能会影响人口的寿命，这是低收入国家最难克服的部分之一，因此这影响了诊断界，并对前列腺癌诊断市场构成了挑战。  

前列腺癌诊断市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。

北美前列腺癌诊断市场北美前列腺癌诊断市场范围和市场规模

前列腺癌诊断市场根据产品类型、诊断类型、年龄组、类型、阶段、样本类型、最终用户和分销渠道分为八个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据产品类型，前列腺癌诊断市场细分为仪器、试剂和耗材以及配件。2021 年，试剂和耗材部分在前列腺癌诊断市场中占据主导地位，因为它包括 PSA 检测产品，这是建议用于初步检测的主要检测。
  • 根据诊断类型，前列腺癌诊断市场分为初步筛查测试和确认测试。2021 年，初步筛查测试部分在前列腺癌诊断市场中占据主导地位，因为初步测试的数量远远超过确认测试的数量。 
  • 根据年龄组，前列腺癌诊断市场分为成人、儿童和老年。2021 年，老年病学在前列腺癌诊断市场中占据主导地位，因为约 60% 的病例是在 65 岁以上的男性中诊断出来的。
  • 根据类型，前列腺癌诊断市场分为前列腺腺癌、小细胞癌和其他。2021 年，前列腺腺癌细分市场在前列腺癌诊断市场中占据主导地位，因为超过 95% 的前列腺癌都是在前列腺腺细胞和前列腺系中发展的腺癌。
  • 根据分期，前列腺癌诊断市场分为局限性前列腺癌、复发性/晚期前列腺癌和去势抵抗性前列腺癌（转移性和非转移性）。2021 年，局限性前列腺癌占据前列腺癌诊断市场的主导地位，因为大约 80% 至 85% 的前列腺癌是在局部或区域阶段发现的，即 I、II 和 III 期。
  • 根据样本类型，前列腺癌诊断市场分为血液、组织、尿液和其他。2021 年，血液部分将主导前列腺癌诊断市场，因为血液是最常见的初步测试（即 PSA 测试）的主要样本，而且由于血液容易获得，血液样本采集程序不太复杂，不需要太多时间，预计这将主导前列腺癌诊断市场。 
  • 根据最终用户，前列腺癌诊断市场细分为独立诊断实验室、医院、癌症研究机构、诊所、门诊手术中心等。2021 年，独立诊断实验室部门将主导前列腺癌诊断市场，因为该部门专门从事各种前列腺癌诊断。
  • 根据分销渠道，前列腺癌诊断市场分为直接招标和零售。2021 年，直接招标部分在前列腺癌诊断市场占据主导地位，因为它们是医疗机构和诊断实验室采购试剂、耗材、设备和配件的主要来源。

前列腺癌诊断市场国家层面分析

对前列腺癌诊断市场进行分析，并按上述国家、产品类型、诊断类型、年龄组、类型、阶段、样本类型、最终用户和分销渠道提供市场规模信息。

北美前列腺癌诊断市场报告涵盖的国家包括美国、加拿大和墨西哥。

北美地区占据前列腺癌诊断市场的大部分份额，预计在预测期内将出现复合年增长率，因为该地区的诊断测试数量不断增加。由于人们对该疾病的认识不断提高，预计美国将在北美前列腺癌诊断市场占据主导地位。  

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。  

制造商的战略举措为前列腺癌诊断市场参与者创造新机遇 

前列腺癌诊断市场还为您提供了每个国家前列腺癌诊断产品销售增长、前列腺癌诊断技术进步的影响以及监管环境变化对前列腺癌诊断市场的支持的详细市场分析。数据涵盖 2011 年至 2019 年的历史时期。 

竞争格局和前​​列腺癌诊断市场份额分析

前列腺癌诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对前列腺癌诊断市场的关注有关。 

提供北美前列腺癌诊断市场报告的主要公司包括 F. Hoffmann-La Roche Ltd、ACON Laboratories, Inc.、Teco Diagnostics、Hologic Inc.、Accuquik Test Kits、MDxHealthcare、Abbott、Siemens Healthcare GmbH、OPKO Health Inc.、Myraid Genetics, Inc.、DiaSorin SpA、Beckman Coulter, Inc.（Danaher 的子公司）、Genomic Health, Inc.（Exact Sciences Corporation 的子公司）、bioMérieux SA、Metamark Genetics, Inc.、Fujirebio 和 Eurolyser Diagnostica GmbH 等国内外公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。

全球各地的公司也推出了许多产品并达成了多项协议，这也加速了前列腺癌诊断市场的发展。

例如，  

  • 2021 年 1 月，Hologic Inc. 宣布已同意以 2.3 亿美元收购 Biotheranostics, Inc.。该公司是转移性癌症和乳腺癌分子诊断测试的提供商。完成收购后，Hologic Inc. 将在全球癌症患者肿瘤检测领域取得领先地位，并将增加公司的收入。

市场参与者的合作、合资和其他策略正在增强前列腺癌诊断市场的公司市场，这也为组织改善其在前列腺癌诊断市场的供应提供了好处。   

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. Epidemiology
  6. COMPARATIVE ANALYSIS WITH PARENT MARKET
  7. REGULATORY FRAMEWORK: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN THE U.S.
  8. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  9. IMPACT OF COVID-19 ON NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    6. CONCLUSION
  10. North America PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  11. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  12. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  13. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  14. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  15. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  16. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  17. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  18. NORTH AMERICA prostate cancer diagnostics market, BY Country
    1. u.s.
    2. canada
    3. mexico
  19. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
    1. company share analysis: north america
  20. SWOT
  21. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. product Portfoli0
      4. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. OPko HEALTH INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. ACCUQUIK TEST KITS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. Diasorin s.p.a
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLI0
      4. RECENT DEVELOPMENTS
    10. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    12. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. MDXHEALTHCARE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. Metamark genetics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI0
      3. RECENT DEVELOPMENTS
    16. Myraid genetics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Prostatype Genomics
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. TECO DIAGNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  22. questionnaire
  23. related reports

表格列表

TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988

TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER

TABLE 3 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (USD million)

TABLE 4 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (UNits)

TABLE 5 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 6 NORTH AMERICA preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 7 NORTH AMERICA Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 8 NORTH AMERICA imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 9 NORTH AMERICA Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 10 NORTH AMERICA biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 11 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By type, 2019-2028 (USD million)

TABLE 12 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By age group 2019-2028 (USD million)

TABLE 13 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By Stage, 2019-2028 (USD million)

TABLE 14 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By Sample Type, 2019-2028 (USD million)

TABLE 15 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD million)

TABLE 16 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD million)

TABLE 17 North America PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD million)

TABLE 18 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD million)

TABLE 19 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 20 U.S. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 21 U.S. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 22 U.S. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 23 U.S. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 24 U.S. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 25 U.S. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 26 U.S. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD million)

TABLE 27 U.S. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD million)

TABLE 28 U.S. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD million)

TABLE 29 U.S. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD million)

TABLE 30 U.S. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD million)

TABLE 31 U.S. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD million)

TABLE 32 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD million)

TABLE 33 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 34 CANADA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 35 CANADA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 36 CANADA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 37 CANADA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 38 CANADA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 39 CANADA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 40 CANADA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD million)

TABLE 41 CANADA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD million)

TABLE 42 CANADA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD million)

TABLE 43 CANADA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD million)

TABLE 44 CANADA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD million)

TABLE 45 CANADA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD million)

TABLE 46 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD million)

TABLE 47 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 48 MEXICO Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 49 MEXICO Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 50 MEXICO Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 51 MEXICO Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 52 MEXICO Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 53 MEXICO Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 54 MEXICO Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD million)

TABLE 55 MEXICO Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD million)

TABLE 56 MEXICO Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD million)

TABLE 57 MEXICO Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD million)

TABLE 58 MEXICO Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD million)

TABLE 59 MEXICO Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD million)

图片列表

FIGURE 1 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation

FIGURE 3 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID

FIGURE 10 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE North America prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the North America prostate cancer diagnostics market in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 15 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2020

FIGURE 16 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2021-2028 (USD MILLION)

FIGURE 17 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, CAGR (2021-2028)

FIGURE 18 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE

FIGURE 19 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, 2020

FIGURE 20 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE 2021-2028 (USD MILLION)

FIGURE 21 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 22 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 23 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2020

FIGURE 24 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2021-2028 (USD MILLION)

FIGURE 25 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, CAGR (2021-2028)

FIGURE 26 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, LIFELINE CURVE

FIGURE 27 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, 2020

FIGURE 28 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group , 2021-2028 (USD MILLION)

FIGURE 29 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, CAGR (2021-2028)

FIGURE 30 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, LIFELINE CURVE

FIGURE 31 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2020

FIGURE 32 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2021-2028 (USD MILLION)

FIGURE 33 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, CAGR (2021-2028)

FIGURE 34 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, LIFELINE CURVE

FIGURE 35 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2020

FIGURE 36 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2021-2028 (USD MILLION)

FIGURE 37 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, CAGR (2021-2028)

FIGURE 38 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, LIFELINE CURVE

FIGURE 39 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2020

FIGURE 40 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2021-2028 (USD MILLION)

FIGURE 41 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, CAGR (2021-2028)

FIGURE 42 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, LIFELINE CURVE

FIGURE 43 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2020

FIGURE 44 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 45 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 46 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution, LIFELINE CURVE

FIGURE 47 North America Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 48 North America Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 49 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 51 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 52 north america Prostate cancer diagnostics market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

浏览相关页面

Banner